GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytori Cell Research Institute Inc (TSE:3750) » Definitions » Price-to-Owner-Earnings

Cytori Cell Research Institute (TSE:3750) Price-to-Owner-Earnings : (As of Jun. 10, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Cytori Cell Research Institute Price-to-Owner-Earnings?

As of today (2024-06-10), Cytori Cell Research Institute's share price is 円1015.00. Cytori Cell Research Institute does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Cytori Cell Research Institute's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Cytori Cell Research Institute was 234.60. The lowest was 5.76. And the median was 10.92.


TSE:3750's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 33.7
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-10), Cytori Cell Research Institute's share price is 円1015.00. Cytori Cell Research Institute's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円-99.67. Therefore, Cytori Cell Research Institute's PE Ratio for today is At Loss.

As of today (2024-06-10), Cytori Cell Research Institute's share price is 円1015.00. Cytori Cell Research Institute's EPS without NRI for the trailing twelve months (TTM) ended in was 円-88.46. Therefore, Cytori Cell Research Institute's PE Ratio without NRI for today is At Loss.

During the past 13 years, Cytori Cell Research Institute's highest PE Ratio without NRI was 230.91. The lowest was 0.00. And the median was 4.50.


Cytori Cell Research Institute Price-to-Owner-Earnings Historical Data

The historical data trend for Cytori Cell Research Institute's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytori Cell Research Institute Price-to-Owner-Earnings Chart

Cytori Cell Research Institute Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cytori Cell Research Institute Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cytori Cell Research Institute's Price-to-Owner-Earnings

For the Biotechnology subindustry, Cytori Cell Research Institute's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cytori Cell Research Institute's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cytori Cell Research Institute's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Cytori Cell Research Institute's Price-to-Owner-Earnings falls into.



Cytori Cell Research Institute Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Cytori Cell Research Institute's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=1015.00/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cytori Cell Research Institute  (TSE:3750) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Cytori Cell Research Institute Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Cytori Cell Research Institute's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Cytori Cell Research Institute (TSE:3750) Business Description

Traded in Other Exchanges
N/A
Address
1-1-1 Otemachi, Otemachi Park Building, Chiyoda-ku, Tokyo, JPN, 100-0004
Cytori Cell Research Institute Inc developing a new clinical approach to cell therapy to provide better medical care to patients by providing medical care that responds to unmet medical needs based on innovative regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.

Cytori Cell Research Institute (TSE:3750) Headlines

No Headlines